-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
NIKA PHARMACEUTICALS, INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2020 to 31 Mar 2025.
- NIKA PHARMACEUTICALS, INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $30,000, a 70% decline year-over-year.
- NIKA PHARMACEUTICALS, INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $137,419, a 64% increase from 2023.
- NIKA PHARMACEUTICALS, INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $83,565, a 144% increase from 2022.
- NIKA PHARMACEUTICALS, INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $34,180, a 153% increase from 2021.